Jasper Therapeutics (NASDAQ:JSPR) Stock Rating Reaffirmed by HC Wainwright
HC Wainwright reiterated their buy rating on shares of Jasper Therapeutics (NASDAQ:JSPR – Free Report) in a research report released on Tuesday morning, Benzinga reports. The firm currently has a $65.00 price objective on the stock. JSPR has been the topic of a number of other reports. Cantor Fitzgerald reaffirmed an “overweight” rating on shares […]
More Stories
Maverix Metals (CVE:MMX) Trading 4.7% Higher – What’s Next?
Maverix Metals Inc (CVE:MMX – Get Free Report)’s share price was up 4.7% during trading on Thursday . The company...
Uniserve Communications (CVE:USS) Trading Up 14.3% – What’s Next?
Shares of Uniserve Communications Co. (CVE:USS – Get Free Report) rose 14.3% during mid-day trading on Thursday . The stock...
WisdomTree Emerging Markets High Dividend Fund (NYSEARCA:DEM) Stock Price Down 0.3% – Here’s What Happened
WisdomTree Emerging Markets High Dividend Fund (NYSEARCA:DEM – Get Free Report)’s share price fell 0.3% during trading on Thursday ....
Reserve Petroleum (OTCMKTS:RSRV) Stock Price Down 6.2% – What’s Next?
The Reserve Petroleum Company (OTCMKTS:RSRV – Get Free Report) traded down 6.2% during mid-day trading on Thursday . The company...
Keystone Law Group (LON:KEYS) Stock Price Down 1.8% – Here’s Why
Keystone Law Group plc (LON:KEYS – Get Free Report)’s share price dropped 1.8% during trading on Thursday . The stock...
GreenPower Motor (CVE:GPV) Stock Price Up 38.1% – Still a Buy?
GreenPower Motor Company Inc. (CVE:GPV – Get Free Report) traded up 38.1% during mid-day trading on Saturday . The stock...